PortfoliosLab logoPortfoliosLab logo
UL vs. CAH
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UL vs. CAH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Unilever Group (UL) and Cardinal Health, Inc. (CAH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UL achieves a -8.35% return, which is significantly lower than CAH's 9.47% return. Over the past 10 years, UL has underperformed CAH with an annualized return of 5.33%, while CAH has yielded a comparatively higher 14.31% annualized return.


UL

1D
1.03%
1M
3.45%
YTD
-8.35%
6M
-7.70%
1Y
-14.93%
3Y*
5.05%
5Y*
0.66%
10Y*
5.33%

CAH

1D
1.22%
1M
20.12%
YTD
9.47%
6M
13.51%
1Y
41.03%
3Y*
38.77%
5Y*
33.47%
10Y*
14.31%
*Multi-year figures are annualized to reflect compound growth (CAGR)

UL vs. CAH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UL
The Unilever Group
-8.35%5.96%20.90%-0.17%-2.82%-7.61%9.04%12.88%-2.34%40.15%
CAH
Cardinal Health, Inc.
9.47%76.25%19.01%34.15%54.08%-0.40%10.09%18.04%-24.50%-12.65%

Correlation

The correlation between UL and CAH is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Jan 4, 1988

0.23

Fundamentals

Market Cap

UL:

$129.35B

CAH:

$52.83B

EPS

UL:

€5.06

CAH:

$6.55

PE Ratio

UL:

10.06

CAH:

34.17

PEG Ratio

UL:

1.97

CAH:

0.81

PS Ratio

UL:

1.09

CAH:

0.21

Total Revenue (TTM)

UL:

€109.27B

CAH:

$250.55B

Gross Profit (TTM)

UL:

€90.89B

CAH:

$9.23B

EBITDA (TTM)

UL:

€24.12B

CAH:

$2.79B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UL vs. CAH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UL
UL Risk / Return Rank: 1616
Overall Rank
UL Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
UL Sortino Ratio Rank: 1414
Sortino Ratio Rank
UL Omega Ratio Rank: 1515
Omega Ratio Rank
UL Calmar Ratio Rank: 2121
Calmar Ratio Rank
UL Martin Ratio Rank: 1515
Martin Ratio Rank

CAH
CAH Risk / Return Rank: 8080
Overall Rank
CAH Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
CAH Sortino Ratio Rank: 8181
Sortino Ratio Rank
CAH Omega Ratio Rank: 8181
Omega Ratio Rank
CAH Calmar Ratio Rank: 7676
Calmar Ratio Rank
CAH Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UL vs. CAH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Unilever Group (UL) and Cardinal Health, Inc. (CAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ULCAHDifference
Sharpe ratioReturn per unit of total volatility

-2.07

Sortino ratioReturn per unit of downside risk

-3.11

Omega ratioGain probability vs. loss probability

0.90

1.30

-0.40

Calmar ratioReturn relative to maximum drawdown

-0.60

2.02

-2.62

Martin ratioReturn relative to average drawdown

-1.23

5.31

-6.54

UL vs. CAH - Sharpe Ratio Comparison

The current UL Sharpe Ratio is -0.70, which is lower than the CAH Sharpe Ratio of 1.38. The chart below compares the historical Sharpe Ratios of UL and CAH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

UL vs. CAH - Drawdown Comparison

The maximum UL drawdown since its inception was -53.55%, smaller than the maximum CAH drawdown of -61.93%. Use the drawdown chart below to compare losses from any high point for UL and CAH.


Loading charts...

Drawdown Indicators


ULCAHDifference

Max Drawdown

Largest peak-to-trough decline

-53.55%

-61.93%

+8.38%

Max Drawdown (1Y)

Largest decline over 1 year

-25.09%

-20.42%

-4.67%

Max Drawdown (3Y)

Largest decline over 3 years

-25.09%

-20.42%

-4.67%

Max Drawdown (5Y)

Largest decline over 5 years

-26.53%

-22.80%

-3.73%

Max Drawdown (10Y)

Largest decline over 10 years

-30.13%

-46.13%

+16.00%

Current Drawdown

Current decline from peak

-19.64%

-2.39%

-17.25%

Average Drawdown

Average peak-to-trough decline

-10.61%

-15.94%

+5.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.20%

7.75%

+4.45%

Volatility

UL vs. CAH - Volatility Comparison

The current volatility for The Unilever Group (UL) is 6.11%, while Cardinal Health, Inc. (CAH) has a volatility of 7.19%. This indicates that UL experiences smaller price fluctuations and is considered to be less risky than CAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ULCAHDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.11%

7.19%

-1.08%

Volatility (6M)

Calculated over the trailing 6-month period

16.78%

20.32%

-3.54%

Volatility (1Y)

Calculated over the trailing 1-year period

21.50%

30.30%

-8.80%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.87%

25.24%

-4.37%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.61%

29.26%

-7.65%

Dividends

UL vs. CAH - Dividend Comparison

UL's dividend yield for the trailing twelve months is around 3.87%, more than CAH's 0.91% yield.


PositionTTM20252024202320222021202020192018201720162015
CAH
Cardinal Health, Inc.
0.91%0.99%1.28%1.98%2.57%3.80%3.62%3.80%4.24%3.00%2.41%1.68%
UL
The Unilever Group
3.87%3.51%3.29%3.83%3.57%3.77%3.07%3.18%3.49%2.80%3.42%3.02%

Financials

UL vs. CAH - Financials Comparison

This section allows you to compare key financial metrics between The Unilever Group and Cardinal Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B30.00B40.00B50.00B60.00B70.00B202120222023202420252026
18.38B
60.94B
(UL) Total Revenue
(CAH) Total Revenue
Please note, different currencies. UL values in EUR, CAH values in USD

UL vs. CAH - Profitability Comparison

The chart below illustrates the profitability comparison between The Unilever Group and Cardinal Health, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%100.0%2021202220232024202520260
4.1%
Portfolio components
UL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Unilever Group reported a gross profit of 0.00 and revenue of 18.38B. Therefore, the gross margin over that period was 0.0%.

CAH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported a gross profit of 2.50B and revenue of 60.94B. Therefore, the gross margin over that period was 4.1%.

UL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Unilever Group reported an operating income of 4.13B and revenue of 18.38B, resulting in an operating margin of 22.5%.

CAH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported an operating income of 509.00M and revenue of 60.94B, resulting in an operating margin of 0.8%.

UL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Unilever Group reported a net income of 2.56B and revenue of 18.38B, resulting in a net margin of 14.0%.

CAH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported a net income of 399.00M and revenue of 60.94B, resulting in a net margin of 0.7%.


Frequently Asked Questions


UL and CAH have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CAH has higher volatility (7.19%) compared to UL (6.11%). In terms of maximum drawdown, UL dropped -53.55% vs CAH's -61.93%.

CAH currently has the higher Sharpe Ratio (1.38 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UL and CAH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer